Foley & Lardner LLP senior counsel Roberto Fernandez assessed new procedures at the U.S. Patent and Trademark Office (USPTO) in the Law360 article, “New Procedures Expected To Result In More PTAB Denials.”
Commenting on a memo from the acting USPTO director intended to address the Patent Trial and Appeal Board’s (PTAB) “workload needs,” Fernandez said “it’s almost as it that’s now a factor in the discretionary denial analysis, which previously didn’t exist.”
“I think what you’ll see is each of these bullet points fleshed out in short order,” and that will “lay the groundwork for future PTAB institution decisions,” he added.
(Subscription required)
People
Related News
July 21, 2026
In the News
Foley's Raleigh Office Move Spotlighted by Law.com
Foley & Lardner LLP's Raleigh office is featured in Law.com for its relocation to Tower 5 in the North Hills Innovation District (NHID) in Midtown Raleigh.
July 20, 2026
In the News
Thomas Ferrante Weighs in on CMS’ Proposed Changes to Remote Patient Monitoring Services
Foley & Lardner LLP partner Thomas Ferrante commented on the Centers for Medicare & Medicaid Services’ (CMS) proposed changes to remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) in the Report on Medicare Compliance article, “CMS Flips the Script of RPM and RTM in Proposed 2027 MPFS Rule."
July 13, 2026
In the News
Judith Waltz Quoted on OIG Decertification of New York Medicaid Fraud Control Unit
Foley & Lardner LLP partner Judith Waltz was quoted in the Report on Medicare Compliance article, “OPPS Rule Proposes Targeted Reviews of PBDs, New Attestation, More EMTALA Oversight.”